Usted buscó: atherosclerosis (Inglés - Sueco)

atherosclerosis
ateroskleros

atherosclerosis, nos
ateroskleros

as - atherosclerosis
ateroskleros

atherosclerosis (disorder)
ateroskleros

atherosclerosis (& [nos]) (disorder)
ateroskleros

atherosclerosis (morphologic abnormality)
ateroskleros

atherosclerosis [disease/finding]
ateroskleros

atherosclerosis excl heart/brain
arterioskleros exkl hjarta/hjarna

atherosclerosis/peripheral vascular disease
annan obstruktiv/perifer karlsjukdom

if your arteries are narrowed by disease (atherosclerosis)
om du har förträngningar i artärerna p g a sjukdom (åderförkalkning)

atherosclerosis such as myocardial infarction, atrioventricular block, tricuspid valve incompetence
ateroskleros såsom hjärtinfarkt, atrioventrikulärt block, tricuspidalisinsufficiens

you have a condition of hardening of arteries (also known as atherosclerosis), and
du lider av åderförkalkning (även känt som ateroskleros), och

in the atorvastatin group (n=253), there was no progression of atherosclerosis.
sällsynta: hepatit, kolestas med ikterus

angina unstable, aortic valve incompetence, coronary artery atherosclerosis, sinus bradycardia, ventricular hypertropy
instabil angina, hjärtklaffsinsufficiens, kranskärlsateroskleros, sinusbradykardi, ventrikelhypertrofi

prasugrel’s pharmacokinetics are similar in healthy subjects, patients with stable atherosclerosis, and patients undergoing percutaneous coronary intervention.
prasugrels farmakokinetik är likartad hos friska försökspersoner, patienter med stabil ateroskleros och patienter som genomgår perkutan koronarintervention.

if you suffer from hardening of the arteries (“atherosclerosis”) there is an increased risk of a blood clot forming in your blood vessels.
om du lider av åderförkalkning (ateroskleros) ökar risken för att en blodpropp bildas i blodkärlen.

recommendations of the second joint task force of european and other societies on coronary prevention” in atherosclerosis 140 (1998) 199-270.
anpassat efter ” prevention of coronary heart disease in clinical practice; recommendations of the second joint task force of european and other societies on coronary prevention ” i atherosclerosis 140 (1998) 199- 270.

plac i (pravastatin limitation of atherosclerosis in the coronary arteries), plac ii (pravastatin, lipids and atherosclerosis in the carotid arteries), regress (regression growth evaluation statin study), kaps (kuopio atherosclerosis prevention study), care and lipid studies.
carotid arteries), regress - (regression growth evaluation statin study), kaps - (kuopio atherosclerosis prevention study), care - och lipid- studierna.